Microbiology

Search results

• Monkeypox does not seem to be as much of a threat as COVID.

  Gustavo Palacios

  25/05/22

  1 item of Media coverage

  Press/Media

• Monkeypox does not appear to be a threat the size of COVID-19

  Gustavo Palacios

  25/05/22

  1 item of Media coverage

  Press/Media

• Is monkeypox looking like Covid-sized threat?

  Gustavo Palacios

  24/05/22

  1 item of Media coverage

  Press/Media

• Monkeypox isn’t looking like a Covid-19-sized threat

  Gustavo Palacios

  24/05/22

  3 items of Media coverage

  Press/Media

• Durability and effectiveness of immune response against COVID-19: Study

  Viviana Simon

  22/05/22 → 24/05/22

  5 items of Media coverage

  Press/Media

• Monkeypox Isn’t Looking Like a Covid-Sized Threat

  Gustavo Palacios

  23/05/22

  1 item of Media coverage

  Press/Media

• Study shines light on longevity of COVID-19 immune response

  Viviana Simon

  19/05/22 → 23/05/22

  7 items of Media coverage

  Press/Media

• Study sheds light on the longevity of immune response to COVID-19

  Viviana Simon

  20/05/22 → 21/05/22

  7 items of Media coverage

  Press/Media

• Study Shines Light on Longevity of COVID-19 Immune Response

  Viviana Simon

  20/05/22

  1 item of Media coverage

  Press/Media

• Model Medicines Announces AI-Discovered Oral Antiviral Therapeutic, MDL-001, Has Demonstrated Potential Best-In-Class Combination Of Viral Load Reduction, Symptom Reduction, Activity Against SARS-CoV-2 Variants And Pan Antiviral Activity

  Kris White, & Adolfo Garcia-Sastre,

  20/05/22

  1 item of Media coverage

  Press/Media

• STUDY SHINES LIGHT ON LONGEVITY OF COVID-19 IMMUNE RESPONSE

  Viviana Simon

  19/05/22

  1 item of Media coverage

  Press/Media

• Research shines light on longevity of Covid immune response

  Viviana Simon

  19/05/22

  1 item of Media coverage

  Press/Media

• Omicron BA.2.12.1 in PH: What you need to know

  Benjamin tenOever,

  19/05/22

  2 items of Media coverage

  Press/Media

• New study helps to better understand re-infection rates and correlates of protection for SARS-CoV-2

  Viviana Simon

  19/05/22

  2 items of Media coverage

  Press/Media

• Model Medicines Announces AI-Discovered Oral Antiviral Therapeutic, MDL-001, Has Demonstrated Potential Best-In-Class Combination of Viral Load Reduction, Symptom Reduction, Activity Against SARS-CoV-2 Variants and Pan Antiviral Activity.

  Kris White, & Adolfo Garcia-Sastre,

  17/05/22

  35 items of Media coverage

  Press/Media

• Two Leading Mount Sinai Brain Scientists Elected to the National Academy of Sciences

  Eric Nestler, Adolfo Garcia-Sastre,, Helen Mayberg, & Miriam Merad

  5/05/22

  2 items of Media coverage

  Press/Media

• Third Dose of COVID-19 Vaccine Significantly Increases Immune Responses in Most Patients With Multiple Myeloma

  Samir Parekh & Viviana Simon

  4/05/22

  1 item of Media coverage

  Press/Media

• Aspen Institute: Aspen Ideas - Health Announces 2022 Speakers

  Peter Palese & Helen Mayberg,

  3/05/22

  1 item of Media coverage

  Press/Media

• What You Need to Know About New Omicron Subvariants

  Benjamin tenOever,

  21/04/22

  1 item of Media coverage

  Press/Media

• Are New Omicron Subvariants a Threat? How Scientists are Keeping Watch

  Benhur Lee,

  18/04/22 → 19/04/22

  2 items of Media coverage

  Press/Media

• Scientific Consortium Established by National Institutes of Health Provides Real-Time Risk Assessment of SARS-CoV-2 Variants on Immune Protection

  Honoratus Van Bakel, Adolfo Garcia-Sastre,, Viviana Simon & Randy Albrecht,

  31/03/22 → 8/04/22

  3 items of Media coverage

  Press/Media

• COVID-19 and the heart: Can SARS-CoV-2 cause arrhythmia?

  Benjamin tenOever,

  8/04/22

  1 item of Media coverage

  Press/Media

• Third Dose of COVID-19 Vaccine Significantly Increases Immune Responses in Most Patients With Multiple Myeloma

  Samir Parekh & Viviana Simon

  6/04/22 → 8/04/22

  13 items of Media coverage

  Press/Media

• Third dose of COVID-19 vaccine significantly increases immune responses in most patients with multiple myeloma

  Samir Parekh & Viviana Simon

  6/04/22 → 7/04/22

  8 items of Media coverage

  Press/Media